Abbott Sues To Protect Depakote ER

Law360, New York (May 15, 2007, 12:00 AM EDT) -- Abbott Laboratories has filed a lawsuit against an Indian pharmaceutical company and its U.S. subsidiary in a move to stave off efforts to horn in on the billion-dollar U.S. market for the drug Depakote.

Abbott’s complaint, dated May 11, was filed in New Jersey against Wockhardt Ltd. and Wockhardt USA.

Depakote, which is indicated for the treatment of bipolar disorder, epilepsy and migraine headaches, brought in $1.3 billion in global sales for Abbott in 2006, according to the company’s annual report.

Tuesday, an Abbott spokesman said...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.